Better High-Yielding Dividend Stock: Realty Income vs. Pfizer
Dividend stocks are a great way for investors to generate passive income that can be more reliable and predictable than investing in stocks for pure appreciation. While there are no guarantees in the stock market, investors who carefully analyze a company's cash flows and earnings should be able to get a pretty good idea of whether a company can keep paying its Dividend, and if it is poised to gradually increase its quarterly Dividend each year.
Both Realty Income (NYSE: O) and (NYSE: PFE) are two companies with high-yielding dividends and that have paid dividends for many years. Let's take a look at each and see which one is the better dividend stock to own.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Stock
€21.74
-3.400%
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a positive potential of 24.22% for Pfizer Inc. compared to the current price of 21.74 €.
